Addendum to vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis.

  title={Addendum to vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis.},
  author={Alialdo Dantas Damascena and Laylla Mirella Galv{\~a}o Azevedo and Tarcio de Almeida Oliveira and Jerusa da Mota Santana and Marcos Pereira},
  journal={Critical reviews in food science and nutrition},


Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
Findings appear to support a role of vitamin D status in COVID-19 risk, and randomized clinical trials are needed to determine whether broad population interventions and interventions among groups at increased risk ofitamin D deficiency and CO VID-19 could reduce COVIDs19 incidence.
Association of vitamin D with the modulation of the disease severity in COVID-19
Vitamin D, ACE concentrations, and neutrophil to lymphocyte ratio (NLR) were measured in patients with confirmed COVID-19 in comparison with control group and demonstrated significant alterations in vitamin D and ACE levels as well as NLR in the patients’ group.
Factors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients
This study confirms race and ethnicity as predictors of severe COVID-19 and identifies clinical risk factors not previously reported such as vitamin D deficiency, hypercholesterolemia, osteoarthritis, and anemia.
Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank
Abstract Background We examined whether the greater severity of coronavirus disease 2019 (COVID-19) amongst men and Black, Asian and Minority Ethnic (BAME) individuals is explained by
Interaction between age and vitamin D deficiency in severe COVID-19 infection.
In this retrospective study, vitamin D deficiency showed a signal of association with severe COVID-19 infection, suggesting VDD may have a greater impact in younger patients, and should be confirmed in larger, prospective, adequately powered studies.
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
It is concluded that low plasma 25(OH)D levels appear to be an independent risk factor for COVID‐19 infection and hospitalization.
Low serum 25-hydroxyvitamin D (25D) levels in patients hospitalised with COVID-19 are associated with greater disease severity: results of a local audit of practice.
It was found that patients requiring ITU admission were more frequently vitamin D deficient than those managed on medical wards, despite being significantly younger, and no association with fatality was found, potentially due to small sample size, limitations of no-trial data and, potentially, the prompt diagnosis and treatment of VDD.
Nutritional status of patients with COVID-19
The results suggest that a deficiency of vitamin D or selenium may decrease the immune defenses against COVID-19 and cause progression to severe disease.
Patterns of COVID-19 Mortality and Vitamin D: An Indonesian Study
This is a retrospective cohort study which included two cohorts (active and expired) of 780 cases with laboratory-confirmed infection of SARS-CoV-2 in Indonesia